Blog Voices from the Frontlines
In the August 2018 issue
- ASA Brings Model Cannabis Legislation to Lawmakers
- Disabilities Focus of Presentation, Outreach in Chicago
- ASA Science and Standards Work Has International Reach
- Upcoming ASA Events
- PFC Certifying Analytic Labs and other Cannabis Businesses
- Missouri Voters to Choose Between 3 Medical Cannabis Initiatives
- ASA Activist Profile, Nic Easley, Denver, Colorado
- ACTION ALERT: Register to Vote and Vote MMJ
From July 29 through August 2, Americans for Safe Access attended the annual National Conference of State Legislators (NCSL) in Los Angeles, California. We joined over 5,000 conference attendees (about 1,200 of which were state lawmakers or state legislative staff) to promote the goals of our End Pain, Not Lives Campaign.
For Immediate Release: August 1st, 2018
Contact: Dr. Jahan Marcu | 215-828-9183 | Jahan@safeaccessnow.org
California Laboratory Achieves National Certification
Los Angeles, CA – Americans for Safe Access (ASA) is pleased to announce that Consumer Safety Analytics (AKA CannaSafe) Laboratory of Van Nuys, California has been certified for laboratory analysis of medical cannabis products under ASA’s Patient Focused Certification (PFC) program. PFC is a project of ASA, and the only nonprofit, third-party certification program for the medical cannabis industry based on quality standards issued by the American Herbal Products Association (AHPA) and the American Herbal Pharmacopoeia (AHP).
One of Florida’s largest medical marijuana businesses forced to stop processing pot - Americans for Safe Access
By Elizabeth Koh for the Tampa Bay Times
"Surterra will comply with all of the regulations set forth by the Department of Health in order to ensure that Floridians continue to receive the safest, most naturally derived treatments to enable health and well-being, as recommended by a doctor," said company spokeswoman Kim Hawkes in a statement. "We are going above and beyond simply ensuring good manufacturing practices and are pursuing American's For Safe Access' [ASA] Patient Focused Certification Program, which is a standard that is superior to what is currently required by Florida statute."
In the July 2018 Issue:
- FDA Approves First Medicine Derived from Cannabis
- World Health Organization Takes First Steps to Reschedule Cannabis
- New Bipartisan Congressional Bill to Respect State Cannabis Laws
- Oklahoma Voters Pass Robust Medical Cannabis Initiative
- Activist Profile: Christy and Mark Zartler, ASA 2018 Courage Award
- ACTION ALERT: Urge Congress to Pass the STATES Act
Oklahoma Legalized Medical Marijuana, to the Likely Dismay of Scott Pruitt - Americans for Safe Access
By Thomas Mitchell for Westword
"Question 788 is a tremendous victory for patients and for access to medical cannabis. We hope we can replicate this success in Utah and Missouri this November when those states will vote on improving their medical cannabis programs,"- David Mangone
Washington, DC — The Food and Drug Administration (FDA) has approved a drug that contains an active ingredient derived from the cannabis plant. The drug, Epidiolex, an oral solution containing cannabidiol (CBD), will be the first and only FDA-approved CBD drug on the market. The FDA has approved Epidiolex for use only in the treatment of two rare seizure disorders (Dravet Syndrome and Lennox-Gastaut Syndrome), and is the first FDA-approved treatment for patients suffering from Dravet syndrome. While there have been other medications that mimic the natural cannabinoids found in cannabis that have received FDA approval, Epidiolex is the first non-synthetic medication to be derived directly from the cannabis plant. The FDA’s approval of Epidiolex shows that it is possible to make medications from complex plant extracts.
Thanks to the results from recently-permitted scientific studies and the untiring work of cannabis activist groups, more and more people are beginning to accept that cannabis is a successful form of treatment for certain medical conditions. Despite this, many patients out there are still hesitant to try it. Their reasoning may stem from religious beliefs, or perhaps because they’re fearful of losing their job. Oftentimes, however, patients are wary of things that seem to be outside of the current medical system and choose not to explore the benefits of medical cannabis.
Although there are medical cannabis programs of some kind in 47 states, DC, Guam, and Puerto Rico, medical cannabis still remains a mystery to the vast majority of Americans today. Using medical cannabis is an approach that is supported by research and medical professionals, and has demonstrated positive public health outcomes. While it may feel like an overwhelming experience for many new patients, it does not have to be, to help new patients feel comfortable entering the world of medical cannabis, Americans for Safe Access (ASA), the country’s largest medical cannabis patient advocacy group created Cannabis Care Certification, a medical cannabis education program for patients and caregivers. To help you start out this process, here is a list of top 5 things that all patients should know when considering medical cannabis as part of their health care regime.